A brief introduction to the Clinical Trials Network of Tennessee (CTN2), presented by Dr. Steven Goodman, President & CEO of CTN2, and Phil Cestaro, Executive Director and Treasurer of CTN2.
- February 10, 2021
Researchers, Join us today, Friday, February 12, 2021 at 1:00pm via Zoom for our next Health Sciences Entrepreneurship Grand Rounds seminar series. This webcast series features successful and engaging scientists who have proven experience in entrepreneurial ventures. Our speaker this month is Bryan McRae, Ph.D., practicing otolaryngologist (Ear, Nose and Throat surgery) and Executive Director (Interim) of the Center for Medical Innovation at the University Utah School of Medicine. Dr. Wall will present on “Surgical Device Development and Entrepreneurship,” a talk which will highlight CMI’s experience with surgical devices and medical software development, including insights and advice for aspiring faculty inventors in academic health systems. Register for the webinar here: https://utah.zoom.us/j/97465945198 More information can be found on the Office of Research website. This presentation is open to all faculty, staff, and students.
- January 26, 2021
Webinar Registration Link: https://tennesseehipaa.zoom.us/webinar/register/WN_mUslXBRBQ3S46xIFebLZ3w Please join the UTHSC Office of Research Development for the January 2021 Health Sciences Entrepreneurship Grand Rounds featuring Jonathan Wall, PhD. Wednesday, January 27, 2021 1:00pm-2:00pm CT Presenter: Jonathan Wall, PhD Title: The Road to a Collaborative Corporate-Academic Partnership for Biotechnology In this webinar, Dr. Wall will describe the process of going from invention disclosure to viable Biotech start-up and the decision processes that have led to an effective, productive corporate-academic collaboration. Jonathan Wall, PhD is a Professor at the University of Tennessee Graduate School of Medicine, Director of the Amyloidosis and Cancer Theranostics Program, and Director of Research at the Graduate School of Medicine, Knoxville, TN. He is also co-founder and interim Chief Scientific Officer of Attralus Inc., an early phase Biotech company developing diagnostic and therapeutic agents for systemic amyloidosis. _________________________________________ The Health Sciences Entrepreneurship (HSE) Grand Rounds seminar series is a collaboration among UAMS, Univeristy of Alabama at Birmingham, University of Kentucky, University of New Mexico, University of Utah (all Clinical and Translational Science Awards Program institutions), and the University of Tennessee Health Science Center.